AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 MAR 6 - (NewsRx.com & NewsRx.net) -- According to recent research from Switzerland, "angiogenesis is a key process in a variety of human diseases, including cancer. The ability to target selectively the tumor vasculature is potentially useful for the diagnosis and treatment of cancer. Still, little information is available regarding markers that are restricted to the endothelial cells of tumor vessels."
"cDNA array technology allows simultaneous analysis of relative expression levels of a broad spectrum of genes in two related cell populations. We used this technology with the aim of identifying markers specific for tumor ECs (TECs)," wrote M.C. Schmid and colleagues, University of Bern.
"TECs were isolated by CD31-mediated immunomagnetic separation from tumors induced by subcutaneous injection of NF9006 breast carcinoma cells into syngeneic mice. Normal ECs (NECs) were isolated from lactating mammary glands. The endothelial nature of isolated cells was confirmed by RT-PCR using CD31-specific primers and by uptake of Dil-Ac-LDL," researchers said.
"Macrophage contamination in the EC isolations could be reasonably ruled out by assessing the expression of the macrophage marker c-fms. P-32-labeled cDNA probes generated by reverse transcription from total RNA were hybridized to mouse-specific gene arrays. Several genes consistently showed differential expression between TECs and NECs."
"However, expression of only one of ...